We are delighted to have been shortlisted as a finalist for the CPhI Award in the Excellence in Pharma: Formulation category. The nomination is an overwhelming validation of the excellence of our technology. Our best-in-class CESS® nanonization process remains the only technique on the market capable of uniformly producing crystalline or amorphous drug particles from solution as small as 10nm and without excipients.

By dramatically increasing the surface area of drug particles, this addresses a major contributor to attrition in the pharmaceutical pipeline by improving solubility. We will be celebrating with the other nominees on November 5th at CPhI Worldwide, the world’s largest pharmaceutical manufacturing conference, as we await the announcement of the final winner.

You can find the full list of nominees here: https://awards.cphi.com/finalists/